Clinical Trial Update: Maraviroc Immune Recovery Study [Phase 4]

View source ↗

Summary

This entry notes that the Phase 4 clinical trial evaluating Maraviroc (Selzentry) for HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Selzentry (Maraviroc)

Snippet

Sponsor: S.F.L. van Lelyveld | Conditions: HIV Infections | Phase 4 | Status: COMPLETED